JOURNAL OF UROLOGY Journal
Overview
publication venue for
- Impact of Prostate Health Index Results for Prediction of Biopsy Grade Reclassification During Active Surveillance. 208:1037-1045. 2022
- Apalutamide plus Androgen Deprivation Therapy for Metastatic Castration-Sensitive Prostate Cancer: Analysis of Pain and Fatigue in the Phase 3 TITAN Study. 206:914-922. 2021
- Restriction Spectrum Imaging-Magnetic Resonance Imaging to Improve Prostate Cancer Imaging in Men on Active Surveillance. 206:44-51. 2021
- Magnetic Resonance Imaging for the Detection of High Grade Cancer in the Canary Prostate Active Surveillance Study. 204:701-706. 2020
- African American Race is Not Associated with Risk of Reclassification during Active Surveillance: Results from the Canary Prostate Cancer Active Surveillance Study. 203:727-732. 2020
- Intralesional Collagenase Clostridium histolyticum Causes Meaningful Improvement in Men with Peyronie's Disease: Results of a Multi-Institutional Analysis. 201:777-782. 2019
- Continued 5 alpha-Reductase Inhibitor Use after Prostate Cancer Diagnosis and the Risk of Reclassification and Adverse Pathological Outcomes in the PASS. 201:106-111. 2019
- Quality of Life After Open or Robotic Prostatectomy, Cryoablation or Brachytherapy for Localized Prostate Cancer. 183:1822-1828. 2010
- Androgen Receptor Targeted Treatments of Prostate Cancer: 35 Years of Progress with Antiandrogens 2020
- Androgen Receptor Targeted Treatments of Prostate Cancer: 35 Years of Progress with Antiandrogens 2018
- EXPRESSION OF GENES AND PROTEINS SPECIFIC FOR PROSTATE CANCER 2004
Identity
International Standard Serial Number (ISSN)
- 0022-5347
Electronic International Standard Serial Number (EISSN)
- 1527-3792